August 29, 2025

Arbutus Biopharma (ABUS) Stock Analysis: Exploring a 43% Potential Upside with Breakthrough Therapies

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating infectious diseases. Specializing in..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Examining a Potential 116% Upside in the Biotech Sector

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) stands at the forefront of the biotechnology sector, developing innovative therapies aimed at treating central nervous system (CNS) disorders. With..

Intellia Therapeutics (NTLA) Stock Analysis: Unveiling a 197% Upside Potential in Biotech

Intellia Therapeutics, Inc. (NTLA) is capturing investor attention with its promising advancements in gene editing and an intriguing potential upside. With a market cap of $1.25..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring the 115.95% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a key player in the biotechnology sector, has been capturing investor attention with its innovative approach to antibody-based medicines. Focusing on..

Weave Communications, Inc. (WEAV) Stock Analysis: Exploring a 58.83% Upside Potential

Weave Communications, Inc. (NYSE: WEAV) is making waves in the healthcare sector with its innovative approach to customer experience and payment solutions for small to medium-sized..

Simulations Plus, Inc. (SLP)

⚠️ No article content returned.

..

Immunome, Inc. (IMNM): Analyst Consensus and Growth Potential Signal a 137.93% Upside for Investors

Immunome, Inc. (NASDAQ: IMNM), a promising player in the biotechnology sector, is attracting attention due to its notable potential upside of 137.93%, as suggested by analyst..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Potential Upside of 129% Draws Investor Attention

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is making waves in the biotechnology sector with its promising pipeline of anti-inflammatory and anti-fibrotic drugs. Headquartered in San Diego, California,..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Exploring a Potential 222% Upside in Biotechnology

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology firm, is making waves in the healthcare sector with its promising therapeutic developments for inflammatory bowel disease (IBD)...

InMode Ltd. (INMD) Stock Analysis: Unveiling a 25.91% Return on Equity and a Promising 8.91% Upside

InMode Ltd. (NASDAQ: INMD) continues to capture the attention of investors with its innovative approach in the healthcare sector, specifically within the medical devices industry. Headquartered..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a 136% Potential Upside in Healthcare Innovation

Akebia Therapeutics, Inc. (NASDAQ: AKBA) has been capturing the attention of investors with its promising trajectory in the biopharmaceutical sector, specifically targeting kidney diseases. As a..

Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a 75% Upside Potential in the Biotech Arena

For investors navigating the turbulent waters of the biotechnology sector, Ardelyx, Inc. (NASDAQ: ARDX) stands out as a promising candidate. Positioned in the healthcare sector, Ardelyx..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a 33.18% Upside in the Biotech Sector

For investors with a keen eye on the biotechnology sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) presents a compelling opportunity. The company, which specializes in developing therapies..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Exploring Growth Potential Amidst a 38.60% Revenue Surge

Phibro Animal Health Corporation (NASDAQ: PAHC) has recently captured the attention of investors with a remarkable revenue growth rate of 38.60%. This healthcare sector player, specializing..

Geron Corporation (GERN) Stock Analysis: A 153.50% Potential Upside in the Biotech Arena

Geron Corporation (NASDAQ: GERN) stands at a pivotal point in the biotech sector, capturing investor attention with a substantial market cap of $912.36 million and an..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 47.86% Potential Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a biopharmaceutical company rooted in Switzerland, is making waves in the biotechnology industry with its innovative approach to addressing rare diseases. This article..

SI-BONE, Inc. (SIBN) Investor Outlook: Exploring a 50% Upside Potential in the Medical Devices Sector

For investors with a keen eye on the medical devices sector, SI-BONE, Inc. (NASDAQ: SIBN) presents an intriguing opportunity. Despite a challenging economic environment, SI-BONE’s innovative..

Cooks Coffee updates registered address

Cooks Coffee has changed its registered address to 2/105 Jervois Road, Herne Bay, Auckland 1011, New Zealand...

Frasers Group confirms Board changes with Sir Jon Thompson to Chair

Frasers Group announced that David Daly will step down from the Board at the AGM on 24 September 2025 after eight years of service. Sir Jon..

Apax Global Alpha posts interim NAV decline, backs takeover offer

Apax Global Alpha posted a net asset value of €1.11bn (€2.29/£1.97 per share) as at 30 June 2025, down from €1.23bn at year-end 2024, reflecting currency..
Search

Funds

August 29, 2025

Cooks Coffee updates registered address

Cooks Coffee has changed its registered address to 2/105 Jervois Road, Herne Bay, Auckland 1011, New Zealand...

Frasers Group confirms Board changes with Sir Jon Thompson to Chair

Frasers Group announced that David Daly will step down from the Board at the AGM on 24 September 2025 after eight years of service. Sir Jon Thompson will succeed him as Chair from 1 September 2025, while Andy Lyon is expected to join as a Non-Executive Director, adding financial and governance expertise. Further Board appointments are anticipated as part of the succession process...

Apax Global Alpha posts interim NAV decline, backs takeover offer

Apax Global Alpha posted a net asset value of €1.11bn (€2.29/£1.97 per share) as at 30 June 2025, down from €1.23bn at year-end 2024, reflecting currency movements...
Search

Funds

August 29, 2025

FTSE 100

Funds